The ACC recognizes the hard work and dedication of all Fellows in Training. Take the next step in your career by advancing to an FACC membership – the pinnacle of recognition in cardiology. This ...
SGLT2 inhibitors play an important role in preventing adverse cardiovascular events and improving outcomes in patients with heart failure, diabetes and chronic kidney disease. CardioSmart's updated ...
The following are key points to remember from an international consensus on cardiopulmonary resuscitation (CPR) and emergency cardiovascular care science with treatment recommendations: ...
An expert panel report, one of three in a special series published in JACC: CardioOncology, provides a review of the current evidence for the cardiovascular care of patients before cardiotoxic cancer ...
Showcase your cutting-edge simulator in the ACC.25 Cardio Sim Creator Competition and pave the way for advancements in simulation-based education. Whether you've developed a procedural trainer, a ...
Petersen SR, Bonnesen K, Grove EL, Pedersen L, Schmidt M. The authors conducted a nationwide cohort study of 51,794 patients with VTE who had initiated OAC therapy between 2012-2022. Time-dependent ...
Preventing, detecting and managing cancer therapy-related cardiovascular toxicity (CTR-CVT) is a clear objective during cancer treatment. An expert panel report published in JACC: CardioOncology ...
Join experts from ACC's Prevention of Cardiovascular Disease Section on Wednesday, Dec. 4 at noon ET for a recap of the 2024 American Heart Association (AHA) Scientific Sessions' prevention content ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback